Finland plans more generic substitution
This article was originally published in Scrip
The government of Finland has drafted legislation to allow generic substitution for more products, which might reduce spending on medicines by up to €80 million a year. The government's proposal is opposed by multinationals operating in the country, which say that it might damage bilateral trade relations.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.